Optimal long-term antithrombotic treatment of patients with stable coronary artery disease and atrial fibrillation: “OLTAT registry”

Refining Clinical Risk Stratification for Predicting Stroke and Thromboembolism in Atrial Fibrillation Using a Novel Risk Factor-Based Approach

Gregory Y.H. Lip, Robby Nieuwlaat, Ron Pisters et al. · CHEST Journal · 2009 · 6.6K citations · Full text

Thrombosis, Venous Thrombosis, Cardiovascular Epidemiology +14

2016 ESC Guidelines for the management of atrial fibrillation developed in collaboration with EACTS

Paulus Kirchhof, Stefano Benussi, Dipak Kotecha et al. · European Heart Journal · 2016 · 6.4K citations · Full text

A Novel User-Friendly Score (HAS-BLED) To Assess 1-Year Risk of Major Bleeding in Patients With Atrial Fibrillation

Ron Pisters, Deirdre A. Lane, Robby Nieuwlaat et al. · CHEST Journal · 2010 · 4.4K citations · Full text

Acute Myocardial Infarction, Thrombosis, Stroke +16

Rivaroxaban with or without Aspirin in Stable Cardiovascular Disease

John W. Eikelboom, Stuart J. Connolly, Jackie Bosch et al. · New England Journal of Medicine · 2017 · 2.3K citations · Full text

2016 ESC Guidelines for the Management of Atrial Fibrillation Developed in Collaboration With EACTS

Paulus Kirchhof, Stefano Benussi, Dipak Kotecha et al. · Revista Española de Cardiología (English Edition) · 2016 · 1.8K citations · Full text

Electrophysiological Evaluation, Cardiovascular Disease, Patient Safety +10